Showing results (481-490 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|February 27, 2019
A clinical algorithm to diagnose differences of sex developmentNayla Y León, Alejandra P Reyes, Vincent R Harley
The Lancet. Diabetes & Endocrinology|December 26, 2021
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trialMaria Fleseriu, Alexander Dreval, Irina Bondar, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2021
COVID-19 and metabolic disease: mechanisms and clinical managementCharlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, et al.
The Lancet. Diabetes & Endocrinology|February 8, 2022
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trialTakashi Kadowaki, Joakim Isendahl, Usman Khalid, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2022
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
The Lancet. Diabetes & Endocrinology|October 12, 2019
Cushing's disease-from Minnie G to key issues in the early 21st centuryAlan Kelsall, John Newell-Price
The Lancet. Diabetes & Endocrinology|May 18, 2019
Understanding the mechanisms of reversal of type 2 diabetesRoy Taylor, Ahmad Al-Mrabeh, Naveed Sattar
The Lancet. Diabetes & Endocrinology|April 4, 2022
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 studyWilliam V Tamborlane, Lori M Laffel, Naim Shehadeh, et al.
The Lancet. Diabetes & Endocrinology|April 25, 2022
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trialTadej Battelino, Richard M Bergenstal, Angel Rodríguez, et al.
The Lancet. Diabetes & Endocrinology|April 25, 2022
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trialTim Heise, Andrea Mari, J Hans DeVries, et al.
Pageof 93